Lewy Body Dementia Psychosis
2 clinical trials · Condition
◉ Watch Lewy Body Dementia Psychosis
| Record | Firm | Date |
|---|---|---|
| Phase 3, Open Label Extension Study of ACP-204 in Lewy Body Dementia Psychosis (NCT07095465) | ACADIA Pharmaceuticals Inc. | 2025-11-14 |
| Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis (NCT07029581) | ACADIA Pharmaceuticals Inc. | 2025-08-06 |
Track Lewy Body Dementia Psychosis automatically
Every clearance here is in the API, with alerts when new ones post.